Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients
- PMID: 31005138
- DOI: 10.1016/j.idc.2019.02.006
Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients
Abstract
Despite advances in chemotherapy and supportive care, morbidity and mortality remain high for patients with hematologic malignancies (HMs). Those who require hematopoietic stem cell transplantation (HSCT) often require significant immunosuppression and are subject to a variety of complications. These patients carry multiple risk factors for infectious complications, including the development of invasive fungal infections, compared with the general population. Because antifungal prophylaxis has been widely adopted, there has been a shift away from invasive candidiasis toward invasive mold infections, including breakthrough infections. For patients with HM and HSCT, we outline the epidemiology, manifestations, diagnosis, and treatment of invasive fungal infections.
Keywords: Aspergillosis; Candidiasis; Fungal infections; Hematologic malignancies; Hematopoietic stem cell transplant; Mucormycosis.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.Mycopathologia. 2009 Dec;168(6):299-311. doi: 10.1007/s11046-009-9188-6. Epub 2009 Feb 27. Mycopathologia. 2009. PMID: 19247798 Review.
-
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.Clin Infect Dis. 2018 Oct 30;67(10):1621-1630. doi: 10.1093/cid/ciy473. Clin Infect Dis. 2018. PMID: 29860307 Free PMC article.
-
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations.Blood Rev. 2017 Mar;31(2):17-29. doi: 10.1016/j.blre.2016.09.002. Epub 2016 Sep 17. Blood Rev. 2017. PMID: 27682882 Review.
-
Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient.Infect Dis Clin North Am. 2019 Jun;33(2):361-380. doi: 10.1016/j.idc.2019.02.002. Infect Dis Clin North Am. 2019. PMID: 31005133 Review.
-
Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.J Clin Oncol. 2009 Jul 10;27(20):3398-409. doi: 10.1200/JCO.2008.20.1178. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487382 Review.
Cited by
-
Rhino-orbital-cerebral mucormycosis caused by Rhizopus arrhizus diagnosis via metagenomics next-generation sequencing: a case report.Front Cell Infect Microbiol. 2024 Jul 16;14:1375058. doi: 10.3389/fcimb.2024.1375058. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39081868 Free PMC article.
-
Invasive fungal infections in children with leukemia in a tertiary hospital in Oman: An eight-year review.Curr Med Mycol. 2023 Sep;9(3):16-22. doi: 10.22034/CMM.2023.345108.1447. Curr Med Mycol. 2023. PMID: 38361957 Free PMC article.
-
Dental consensus on HSCT - Part II: dental Care during HSCT.Hematol Transfus Cell Ther. 2023 Jul-Sep;45(3):368-378. doi: 10.1016/j.htct.2023.04.003. Epub 2023 May 30. Hematol Transfus Cell Ther. 2023. PMID: 37321878 Free PMC article. Review.
-
The Fragile Patient: Considerations in the Management of Invasive Mould Infections (IMIs) in India.Cureus. 2023 Apr 24;15(4):e38085. doi: 10.7759/cureus.38085. eCollection 2023 Apr. Cureus. 2023. PMID: 37252469 Free PMC article. Review.
-
Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections.BMC Infect Dis. 2023 May 25;23(1):348. doi: 10.1186/s12879-023-08314-9. BMC Infect Dis. 2023. PMID: 37226103 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
